OTTAWA, Sept. 13, 2011 /CNW/ - The Board of Directors for Nordion Inc.
(TSX: NDN) (NYSE: NDZ), a leading provider of products and services to
the global health science market, declared a quarterly dividend of
US$0.10 per share on the outstanding common shares of the Company. The
dividend is payable on October 1, 2011 to shareholders of record at the
close of business on September 23, 2011.
About Nordion Inc.
Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global specialty health science
company that provides market-leading products used for the prevention,
diagnosis and treatment of disease. We are a leading provider of
medical isotopes, targeted therapies and sterilization technologies
that benefit the lives of millions of people in more than 60 countries
around the world. Our products are used daily by pharmaceutical and
biotechnology companies, medical-device manufacturers, hospitals,
clinics and research laboratories. Nordion has more than 500 highly
skilled employees in three locations. Find out more at www.nordion.com.
Forward Looking Statements
Certain statements contained in this news release constitute
"forward-looking statements". These statements are based on current
beliefs and assumptions of management, however are subject to known and
unknown risks, uncertainties and other factors that may cause actual
results to differ materially from the forward-looking statements in
this news release. For additional information with respect to certain
of these beliefs, assumptions, risks and uncertainties, please refer to
Nordion's Annual Information Form for fiscal 2010 available on SEDAR at
www.sedar.com and on EDGAR on www.sec.gov.
SOURCE Nordion Inc.
For further information:
(613) 592-3400 x.1022